Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas

NCT02409576 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT02409576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02409576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas
Lead sponsor
National University Hospital, Singapore
Phase
Phase 1/2
Overall status
Unknown status
Start date
February 28, 2015
Completion date
September 30, 2020
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ewing sarcoma, rhabdomyosarcoma